Martin Špaček
Martin Špaček publishes mostly in Genetics, Pathology and Forensic Medicine and Immunology, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Immunodeficiency and Autoimmune Disorders.
- World rank
- #5,134,408 of 7,710,434 ranked researchers
- Rank in Czechia
- #18,019 of 39,303
- Works
- 115
- Citations
- 1.9k
- Citations per work
- 16.5
What does Martin Špaček research?
Martin Špaček's work is mostly in Medicine (52%), Immunology and Microbiology (8%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6052.1%
- Medicine6052.1%
- Everything else3832.9%
- Life Sciences1715.0%
- 1Genetics25% of their works
- 2Pathology and Forensic Medicine16% of their works
- 3Immunology8% of their works
- 4Molecular Biology7% of their works
- 5Oncology6% of their works
- 6Pulmonary and Respiratory Medicine5% of their works
Research topics
Which keywords describe Martin Špaček's research?
The keywords of their largest research topics: Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Classification, Lymphoma, Genetic Mutations, Primary Immunodeficiency and Breast Cancer.
- Imatinib
- BCR-ABL
- Kaposi's Sarcoma
- Cytokines
- Breast Cancer
- Genetic Mutations
- Classification
- Chronic Lymphocytic Leukemia
- Rituximab
- Genomic Aberrations
- Lymphoma
- Primary Immunodeficiency
- CDK4/6 Inhibitors
- Epstein-Barr Virus
- Neuroinflammation
- Diagnosis Criteria
- International Myeloma Working Group
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- Rituximab1102 topics
- Chronic Lymphocytic Leukemia691 topic
- Genomic Aberrations691 topic
- Classification411 topic
- Lymphoma411 topic
- Genetic Mutations171 topic
- Primary Immunodeficiency171 topic
- Breast Cancer121 topic
- CDK4/6 Inhibitors121 topic
- Cytokines61 topic
- Epstein-Barr Virus61 topic
- Kaposi's Sarcoma61 topic
- Neuroinflammation61 topic
- BCR-ABL41 topic
- Diagnosis Criteria41 topic
- Imatinib41 topic
- International Myeloma Working Group41 topic
Where does Martin Špaček work?
Martin Špaček's main affiliation in the publication record is Charles University, Czechia.
How many publications and citations does Martin Špaček have?
OpenAlex counts 115 works and 1,898 citations for Martin Špaček, an h-index of 14, ranking #5,134,408 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Martin Špaček
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Martin Špaček. Posts are plain text and can be reported.